A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…
The biotech industry has often been criticized for its lack of gender diversity. While there…
Here’s the list of the European biotech companies, both public and private, that are worth…
Idorsia will start a Phase III trial to study the efficacy of its drug in…
Idorsia has started the first Phase III study in its pipeline to test the drug…
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting…
Actelion's spin-off Idorsia was blessed with a large pipeline and a healthy bank balance. How…
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
Idorsia and Roche have agreed on a research collaboration, with the big pharma getting exclusive…
Idorsia will collaborate with Janssen on the development of its hypertension drug, aprocitentan, which could…